Probiotics for Dogs: What the Evidence Actually Shows

Probiotics are increasingly given to dogs, but the marketing runs well ahead of the evidence. This is a neutral look at what canine research actually shows across diarrhoea and chronic gut disease, what the new 2026 ACVIM consensus recommends, which strains have been studied, how safety works, and why the right first step is almost always a conversation with your vet.

Are probiotics useful for dogs?

For some dogs with specific gut problems, probiotics may help, and they are widely used in veterinary practice for digestive upset.⁶ But usefulness is conditional. It depends on the exact strain, the specific problem, and the individual dog, and for several common uses the evidence is weak or mixed.

Probiotic benefits are strain-specific. The 2014 ISAPP consensus, the reference definition of a probiotic, is explicit that effects attach to specific strains at specific doses.⁵ A benefit shown for one strain in one condition does not carry over to a different strain or a different problem, so the front-of-pack CFU number tells you very little on its own.

The name changed: IBD is now CIE

If you are researching a dog with long-term gut problems, you will hit two different names for the same thing. This is worth clearing up before anything else.

In January 2026 the American College of Veterinary Internal Medicine endorsed a new consensus statement which reached agreement on the term chronic inflammatory enteropathy, abbreviated CIE, and suggests avoiding the term inflammatory bowel disease in dogs.¹

The reasoning is precision. IBD describes a related but not identical group of conditions in human gastroenterology, so borrowing the human label implies an equivalence the evidence does not support. CIE covers gastrointestinal disorders with persistent or recurrent signs and variable mucosal inflammation, with protein-losing enteropathy and granulomatous colitis treated as phenotypes within that spectrum rather than separate diseases.

Practically: older articles about "dog IBD" and newer veterinary material about "canine CIE" are describing the same patients. Both terms appear on this page for that reason, with the older one used only where a cited study used it.

What the overall canine evidence shows

Canine probiotic research is smaller and more mixed than the human literature. Here is a plain summary of where the evidence stands by area.

What the 2026 ACVIM consensus recommends

This is the current reference point for chronic gut disease in dogs, and it is open access, so you can read it yourself. Three things in it matter to any owner considering a supplement.

Diet comes first. Dietary treatment trials are the preferred first-choice recommendation in clinically stable dogs, before invasive diagnostic tests, at a strong strength of recommendation. Between 38 and 89 percent of dogs with CIE are food-responsive. A proper trial means exclusive feeding of one therapeutic diet for at least two weeks, ideally at least three trials with different diet categories, with weekly clinical scoring. Responses are typically seen within 10 to 14 days.¹

Routine antibiotics are discouraged. Empirical antimicrobial treatment is not recommended in dogs suspected of having CIE, at a strong strength of recommendation. Responses to drugs such as tylosin are usually short-lived, relapse rates after stopping are high, and significant intestinal dysbiosis can persist long-term. Confirmed granulomatous colitis caused by adherent and invasive E. coli is a specific exception requiring sensitivity-guided treatment.

Probiotics are a limited, conditional addition. The panel gives prebiotics, probiotics, synbiotics and faecal microbiota transplantation their own section, and the headline is measured: these have a limited role in the treatment of CIE, but appear well tolerated, at a conditional strength of recommendation. Within that, one product is named. A specific eight-strain probiotic, which the statement identifies as the "De Simone Formulation", might be considered in dogs that have failed dietary treatment trials.

What makes the section genuinely useful is that it reports products separately rather than treating probiotics as one category.

Read the middle of that table honestly. Most of the products tested in dogs with CIE did not beat diet or placebo on clinical outcomes. That is the context any claim about dog probiotics has to sit inside.

Which strains and formulations have been studied

Enterococcus faecium SF68 is one of the better-known strains used in veterinary probiotic products and has been studied in dogs and cats. In a double-blind, placebo-controlled shelter study of 217 cats and 182 dogs (Bybee et al., 2011), the cats fed SF68 had fewer episodes of diarrhoea lasting two days or more than controls. The corresponding effect was not demonstrated in the dogs.³ It appears in dog-specific products in a format made for dogs.

The eight-strain De Simone Formulation is the multi-strain mixture studied in the canine trials below, and the only probiotic named in the 2026 ACVIM consensus. It is the formulation historically sold under the VSL#3 brand until 2016, and older canine and human papers refer to it by that brand name. Post-2016 VSL#3 is a separate product, so brand name alone is not a reliable guide to what was studied.

The key point holds across all of them: what matters is the exact strain or formulation and the evidence attached to it, not the brand name or the size of the CFU number.

Evidence for acute diarrhoea

What the studies found: acute diarrhoea is common in dogs and often resolves on its own. In a randomised, double-blind, placebo-controlled trial in 60 dogs (Shmalberg et al., University of Florida, 2019), dogs reached acceptable stool consistency after about 3.5 days on a probiotic, 4.6 days on metronidazole and 4.8 days on placebo.²

What it means: the probiotic group did slightly better on average, but the differences between the three groups were not statistically significant (p = 0.17). The study also failed to support the routine use of metronidazole in these cases.

The limits: the trial was relatively small, and a larger study would be needed to confirm whether the roughly one-day probiotic advantage is real. Other trials of different products have suggested faster resolution, so the overall picture for acute diarrhoea is genuinely mixed rather than settled.

Evidence for chronic enteropathy

The first trial. In an open-label randomised trial in 20 dogs with idiopathic inflammatory bowel disease, the term used at the time (Rossi et al., PLoS ONE, 2014), dogs given the eight-strain formulation and dogs given prednisone plus metronidazole both improved on clinical activity and duodenal histology scores over 60 days. CD3-positive cells decreased in both arms. The finding specific to the probiotic arm was a rise in FoxP3-positive regulatory immune cells, a marker linked to dampening gut inflammation.⁴

The second trial. A further randomised trial reviewed in the 2026 consensus compared an elimination diet plus prednisone against a combination of diet, prednisolone and the same probiotic over eight weeks. Both treatments produced rapid clinical remission. Histologic inflammation did not improve in either group, but probiotic treatment was associated with upregulated tight junction protein expression.¹

What it means: taken together the ACVIM panel rates these two trials as moderate quality evidence, which is what supports the conditional recommendation. It is a real, peer-reviewed signal that this specific multi-strain formulation can play a supportive role alongside veterinary care.

The limits: both trials were small, both studied dogs already receiving dietary or drug management rather than the probiotic alone, and both were in immunosuppressant-responsive disease. Rossi 2014 was open-label rather than blinded, and the strains were supplied by the manufacturer, which the authors declare. The consensus statement itself carries a declaration that panel co-chair Albert E. Jergens has grants, research funding and consultancies with the company marketing a veterinary product containing this formulation.

None of that makes the findings wrong. It means they are a moderate-quality signal supporting a conditional recommendation, which is exactly how the panel graded them, and not proof of effect in dogs generally.

Where studies found no clear benefit

A balanced guide has to include the trials that did not show a benefit. The 2019 acute-diarrhoea RCT above found no statistically significant advantage for the probiotic over placebo. In dogs with CIE, randomised trials of prebiotics and probiotics in food-responsive disease showed no improvement over an elimination diet alone, a trial of Bifidobacterium animalis NCIMB 41199 found no group differences, and two trials of an Enterococcus faecium synbiotic found no difference in clinical scores, histology or cytokine expression. For healthy dogs with no gut problem, there is little evidence that routine probiotic use delivers a general health benefit.

Safety and higher-risk dogs

Reported tolerability varies by product and study, and probiotics are generally considered well tolerated in healthy dogs. The 2026 ACVIM consensus similarly describes pre-, pro- and synbiotics as seeming well tolerated in dogs with CIE. The group that needs real caution is dogs that are immunocompromised, very young, very old or seriously ill, because live cultures carry more risk in vulnerable animals. Stop the product and contact a vet if symptoms begin, worsen or persist.

Human probiotics versus dog-specific products

Human probiotic supplements are formulated, dosed and authorised for people. In the UK they are regulated by the Food Standards Agency as food supplements. They are not licensed veterinary medicines. Products marketed to treat disease in animals fall under the Veterinary Medicines Directorate, a separate and stricter regime, and products sold for dogs that make no medicinal claims are generally regulated as feed or complementary feed.⁷

Human probiotic supplements are not automatically suitable for dogs. Do not give a human supplement to an animal unless your vet has reviewed the exact product, its ingredients and the proposed use. Dose is a veterinary decision, not a scaled-down guess, and a product made for dogs removes that guesswork.

What to ask your vet